A comparison of oxycodone prolonged-release vs. oxycodone + naloxone prolonged-release after laparoscopic hysterectomy

Autor:	C. E. Bjerkelund, M. Comelon, Erik Qvigstad, K. Wisloeff-Aase, Johan Raeder, H. Undersrud, Harald Lenz, Tomas Drægni
Rok vydání:	2013
Předmět:	Constipation business.industry medicine.drug_class Analgesic Chronic pain General Medicine medicine.disease Anesthesiology and Pain Medicine Naloxone Anesthesia Medicine Defecation medicine.symptom business Oxycodone Opioid antagonist medicine.drug Oxycodone/naloxone
Zdroj:	Acta Anaesthesiologica Scandinavica. 57:509-517
ISSN:	0001-5172
DOI:	10.1111/aas.12051
Popis:	Background Targiniq®, an oxycodone prolonged-release (PR) formulation combined with the opioid antagonist naloxone PR, aims to prevent opioid-induced constipation without impairing the analgesic efficacy. This has been confirmed during prolonged use in chronic pain or cancer patients. The purpose of our study was to compare clinical effects of oxycodone PR with oxycodone PR + naloxone PR for short-term post-operative pain management. Methods This randomised, double-blind, prospective study included 85 women undergoing laparoscopic hysterectomy. The two groups received either oxycodone PR 10 mg or oxycodone PR 10 mg + naloxone PR 5 mg as pre-medication and twice daily for 3 days. As rescue analgesic, the patients received oxycodone intravenous during the first 24 h post-operatively and oxycodone tablets in the 24–72-h period. Constipation, other side effects, pain and satisfaction were registered during the first 7 post-operative days. Results Demographic, pre- and perioperative variables and the use of rescue analgesics were similar in the groups. There were no significant differences in variables related to constipation. In the oxycodone PR + naloxone PR group, 25% had no defecation during the first 72 h post-operatively, compared with 20% in the oxycodone PR group (mean 1.2 ± 1.1 vs. 2.1 ± 2.4 defecations). Other opioid-induced effects and side effects showed no significant differences. Only 7% were dissatisfied with their oral pain treatment. Conclusion Addition of naloxone to oxycodone PR tablets in a pain regimen administered twice daily the first three post-operative days had no significant clinical effects on constipation or other variables during the first week after hysterectomy.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6cc0b317cf6a133b25c68a855c5f97de https://doi.org/10.1111/aas.12051 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.